NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000926

Registered date:03/12/2007

The clinical study whether adult patients with asthma who could withdraw or reduce the treatment of ICSs without exacerbation of disease

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedbronchial asthma
Date of first enrollment2007/12/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)continuing of the ICS therapy for same dose withdrawing of all ICSs

Outcome(s)

Primary OutcomeClinical symptoms, lung function(FEV1, V50, V25), bronchial hyperresponsiveness, eosinophils in sputum and whole blood cells, IgE
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaadult patients with asthma receive more than FP equivalent 400 mg, or with clinical symptoms less than 6 months

Related Information

Contact

public contact
Name Naomi Tsurikisawa
Address 18-1 Sakuradai Minami-ku Sagamihara Kanagawa Japan
Telephone 042-742-8311
E-mail n-tsurikisawa@sagamihara-hosp.gr.jp
Affiliation National Hospital Organization Sagamihara National Hospital Clinical Research Center for Allergy and Rheumatology
scientific contact
Name Naomi Tsurikisawa
Address 18-1 sakuradai sagamihara Japan
Telephone 042-742-8311
E-mail n-tsurikisawa@sagamihara-hosp.gr.jp
Affiliation National Hospital Organization Sagamihara National Hospital Clinical Research Center for Allergy and Rheumatology